Overview

RBBP8 is altered in 0.82% of all cancers with colon adenocarcinoma, lung adenocarcinoma, melanoma, glioblastoma, and esophageal adenocarcinoma having the greatest prevalence of alterations [3].

The most common alterations in RBBP8 are RBBP8 Mutation (2.35%), RBBP8 Amplification (0.27%), RBBP8 V329I (0.07%), RBBP8 Loss (0.06%), and RBBP8 E752Q (0.04%) [3].

Significance of RBBP8 in Diseases

References

1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.